TY - JOUR
T1 - Treatment of Acne with Oral Metronidazole
AU - Oguchi, Motoi
AU - Akamatsu, Hirohiko
AU - Asada, Maki
AU - Kubo, Keiko
AU - Namura, Shouko
AU - Shirai, Kinue
AU - Asada, Yasuo
AU - Nishijima, Setuko
PY - 1987
Y1 - 1987
N2 - Metronidazole (Flagyl®) 375 to 500mg per dey was administered orally to 29 patients (7male, 22 female cases, ranging in age from 10 to 32 years) with acne, consisting of 26 with acne vulgaris, including 5 with cystic type, one with acne aestivalis and two with steroid acne. The period of adMinistration was 1 to 7 weeks, 4 weeks on the average. The drug was considered to be markedly effective in 17 cases in which the eruptions had disappeared or almost disappeared, and effective in 7 cases in which eruptions had decreased, with an overall efficacy rate of 83%. The antibacterial activity of metronidazole against propionibacterium acnes is now being studied.
AB - Metronidazole (Flagyl®) 375 to 500mg per dey was administered orally to 29 patients (7male, 22 female cases, ranging in age from 10 to 32 years) with acne, consisting of 26 with acne vulgaris, including 5 with cystic type, one with acne aestivalis and two with steroid acne. The period of adMinistration was 1 to 7 weeks, 4 weeks on the average. The drug was considered to be markedly effective in 17 cases in which the eruptions had disappeared or almost disappeared, and effective in 7 cases in which eruptions had decreased, with an overall efficacy rate of 83%. The antibacterial activity of metronidazole against propionibacterium acnes is now being studied.
UR - http://www.scopus.com/inward/record.url?scp=0023484682&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023484682&partnerID=8YFLogxK
U2 - 10.11340/skinresearch1959.29.995
DO - 10.11340/skinresearch1959.29.995
M3 - Article
AN - SCOPUS:0023484682
SN - 0018-1390
VL - 29
SP - 995
EP - 1000
JO - skin research
JF - skin research
IS - 6
ER -
